Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Clinical Liver Disease
|
July 24, 2019
Mário G Pessoa, Manuel Mendizábal
Annals of Hepatology
|
January 13, 2026
Name MASLD/MASH - and act on it
Jeffrey V Lazarus, Mário G Pessoa, Debbie L Shawcross, et al.
Hepatology Communications
|
January 12, 2026
Name MASLD/MASH - and act on it
Jeffrey V Lazarus, Mário G Pessoa, Debbie L Shawcross, et al.
JHEP Reports : Innovation in Hepatology
|
February 23, 2026
Name MASLD/MASH - and act on it
Jeffrey V Lazarus, Mário G Pessoa, Debbie L Shawcross, et al.
Annals of Hepatology
|
December 26, 2022
Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial
Roseane P Medeiros, Norah A Terrault, Daniel F Mazo, et al.
Journal of Medical Virology
|
July 22, 2014
Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches
Isabel M V G de Carvalho, Rafael Alves, Polyana A Vasconcelos-Medeiros de Souza, et al.
Drugs in Context
|
July 13, 2016
Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy
Teerha Piratvisuth, Piyawat Komolmit, Henry Ly Chan, et al.
Clinics (Sao Paulo, Brazil)
|
August 22, 2025
Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study
Isabel Veloso Alves Pereira, Ana Beatriz Souza de Oliveira, Patricia Momoyo Yoshimura Zitelli, et al.
Journal of Hepatology
|
August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives
Aleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
Journal of Hepatology
|
April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Homie A Razavi, Maria Buti, Norah A Terrault, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Clinical Liver Disease
|
July 24, 2019
Mário G Pessoa, Manuel Mendizábal
Annals of Hepatology
|
January 13, 2026
Name MASLD/MASH - and act on it
Jeffrey V Lazarus, Mário G Pessoa, Debbie L Shawcross, et al.
Hepatology Communications
|
January 12, 2026
Name MASLD/MASH - and act on it
Jeffrey V Lazarus, Mário G Pessoa, Debbie L Shawcross, et al.
JHEP Reports : Innovation in Hepatology
|
February 23, 2026
Name MASLD/MASH - and act on it
Jeffrey V Lazarus, Mário G Pessoa, Debbie L Shawcross, et al.
Annals of Hepatology
|
December 26, 2022
Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial
Roseane P Medeiros, Norah A Terrault, Daniel F Mazo, et al.
Journal of Medical Virology
|
July 22, 2014
Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches
Isabel M V G de Carvalho, Rafael Alves, Polyana A Vasconcelos-Medeiros de Souza, et al.
Drugs in Context
|
July 13, 2016
Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy
Teerha Piratvisuth, Piyawat Komolmit, Henry Ly Chan, et al.
Clinics (Sao Paulo, Brazil)
|
August 22, 2025
Long-term pioglitazone use in MASLD patients: insights from a multicentric preliminary study
Isabel Veloso Alves Pereira, Ana Beatriz Souza de Oliveira, Patricia Momoyo Yoshimura Zitelli, et al.
Journal of Hepatology
|
August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy lives
Aleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
Journal of Hepatology
|
April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries
Homie A Razavi, Maria Buti, Norah A Terrault, et al.
Page
of 1